ACTIVITIES AND RESULTS
What we do
The entire molecular imaging chain, on a single site
From molecule to patient, Nancyclotep brings together radiochemistry, production, preclinical and clinical research, and support for care. A rare continuity that shortens timelines and moves projects forward faster.
5
complementary activities
under one roof
under one roof
Our disciplines
The main activities of Nancyclotep
1 / 5
-
01
Radiochemistry / radiopharmacy
Laboratories dedicated to the research and development of new tracers, from radiolabelling to process design.
-
02
Preclinical research
Support for investigators across every phase of a project, with a small-animal imaging facility.
-
03
Production
The production of radiopharmaceuticals for clinical research, within a controlled pharmaceutical environment.
-
04
Clinical research
A clinical research unit serving both academic projects and trials sponsored by the pharmaceutical industry.
-
05
Healthcare
Support for the diagnostic and therapeutic activities of the Nuclear Medicine department, as close as possible to the patient.
Contributing to making Nancy the leading Nuclear Medicine department in France: 4 PET-Scans, 5 gamma cameras and 14 rooms dedicated to Targeted Internal Radiotherapy.
Our results
Decisive contributions, in figures
Scientific publications
Clinical studies, phases 1 to 4
PET-Scan examinations (medical activity)
Economic assessment
Results, investment, growth
32
direct jobs created
12M€
invested for the benefit of its 3 members
- A positive result every year since its creation
- R&D laboratories in radiochemistry / radiopharmacy for the University of Lorraine
- 3 PET-Scans and a clinical research team available to the CHRU
A project to move forward?
Clinical trial, tracer development, preclinical study: let’s discuss your needs and see together how the platform can meet them.